| Stage- and tissue-specific expression of the neu oncogene in rat development. | None |
| Activated neu oncogene sequences in primary tumors of the peripheral nervous system induced in rats by transplacental exposure to ethylnitrosourea. | None |
| Development of monoclonal antibodies reactive with the product of the neu oncogene. | None |
| The neu oncogene encodes an epidermal growth factor receptor-related protein. | None |
| Site-specific antibodies to the erbB oncogene product immunoprecipitate epidermal growth factor receptor. | None |
| The neu oncogene: an erb-B-related gene encoding a 185,000-Mr tumour antigen. | None |
| Measuring c-erbB-2 oncogene amplification in fresh and paraffin-embedded tumors by competitive polymerase chain reaction. | None |
| Antigenic and immunogenic mimicry of the HER2/neu oncoprotein by phage-displayed peptides. | None |
| Immunity to the HER-2/neu oncogenic protein. | None |
| Heregulin-dependent regulation of HER2/neu oncogenic signaling by heterodimerization with HER3. | None |
| Inhibition of the oncogene product p185erbB-2 in vitro and in vivo by geldanamycin and dihydrogeldanamycin derivatives. | None |
| erbB-2 oncogene inhibition by geldanamycin derivatives: synthesis, mechanism of action, and structure-activity relationships. | None |
| Inhibition of p185c-erbB-2 proto-oncogene expression by antisense oligodeoxynucleotides down-regulates p185-associated tyrosine-kinase activity and strongly inhibits mammary tumor-cell proliferation. | None |
| HER-2 oncogene is not amplified in primary carcinoma of the fallopian tube. Austrian Cooperative Study Group for Fallopian Tube Carcinoma. | None |
| Up-regulation of urokinase-type plasminogen activator expression by the HER2/neu proto-oncogene. | None |
| Antisense DNA downregulation of the ERBB2 oncogene measured by a flow cytometric assay. | None |
| Substitution of the erbB-2 oncoprotein transmembrane domain activates the insulin receptor and modulates the action of insulin and insulin-receptor substrate 1. | None |
| Downstream signal transduction defects that suppress transformation in two revertant cell lines expressing activated rat neu oncogene. | None |
| Epithelial-myoepithelial carcinoma of salivary glands. A clinicopathologic, DNA flow cytometric, and immunohistochemical study of Ki-67 and HER-2/neu oncogene. | None |
| Expression of c-erbB-2 proto-oncogene-encoded protein (p185erbB-2) in functional rat ameloblasts. | None |